49288-0102 : Cantaloupe .05 g/ml Intradermal; Subcutaneous Injection, Solution
NDC: | 49288-0102 |
Labeler: | Antigen Laboratories, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Cantaloupe |
Dosage Form: | Intradermal; Subcutaneous Injection, Solution |
Application #: | BLA102223 |
Rev. Date: |
NDC Package Codes:
- 49288-0102-1: 2 ML IN 1 VIAL, MULTI‑DOSE (49288‑0102‑1)
- 49288-0102-2: 5 ML IN 1 VIAL, MULTI‑DOSE (49288‑0102‑2)
- 49288-0102-3: 10 ML IN 1 VIAL, MULTI‑DOSE (49288‑0102‑3)
- 49288-0102-4: 30 ML IN 1 VIAL, MULTI‑DOSE (49288‑0102‑4)
- 49288-0102-5: 50 ML IN 1 VIAL, MULTI‑DOSE (49288‑0102‑5)
Active Ingredients:
- Cantaloupe
Dosage Strength:
- .05 g/mL
Pharmaceutical Classes:
- Non-Standardized Food Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Allergens [CS]
- Dietary Proteins [CS]
- Fruit Proteins [EXT]
Related Products:
Based on records with the same trade name.- 0268-6115 Cantaloupe .1 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
- 36987-1306 Cantaloupe .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
- 36987-1307 Cantaloupe .05 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
- 36987-1308 Cantaloupe .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
- 36987-1309 Cantaloupe .1 g/ml Intradermal; Subcutaneous Injection, Solution by Nelco Laboratories, Inc.
- 54575-360 Cantaloupe 1 g/20ml Percutaneous; Subcutaneous Injection, Solution by Allergy Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 49288-0101Next: 49288-0103 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.